Early behavioral and catecholaminergic effects of 6-hydroxydopamine and guanethidine in the neonatal rat. 1975

B A Pappas, and D A Peters, and A K Sobrian, and A Blouin, and B Drew

New born rats received 7 consecutive daily injections of 6-hydroxydopamine (6-OHDA) or guanethidine. Locomotor activity, measured at 3 day intervals, was differentially affected by these drugs, although neither drug elimination a characteristic pattern of ontogeny of locomotor activity. Differing neurochemical effects were also observed. 6-OHDA decreased tyrosine hydroxylase activity in cortex and cerebellum, increased it in the brainstem and had no effect on the hypothalamus. Guanethidine slightly elevated enzyme levels in all four brain regions, with the elevation in brainstem significant at 16 days of age. Regional brain changes in enzyme activity after 4 daily 6-OHDA injections beginning at 1, 5 or 9 days of age indicated that toxic effect of 6-OHDA upon catecholaminergic neurons was age dependent. These data are not consistent with a simple interpretation either in terms of maturational changes in blood brain barrier permeability to 6-OHDA or neuronal uptake of the drug. Further analyses of brainstem areas indicated that the increased brainstem enzyme activity after 6-OHDA was restricted to the pons.

UI MeSH Term Description Entries
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D005260 Female Females
D006145 Guanethidine An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues. ((2-Hexahydro-1(2H)-azocinyl)ethyl)guanidine,Guanethidine Monosulfate,Guanethidine Sulfate,Guanethidine Sulfate (1:1),Guanethidine Sulfate (1:2),Guanethidine Sulfate (2:1),Guanethidine Sulfate (2:1), 14C-Labeled,Ismelin,Isobarin,Octadine,Oktadin,Monosulfate, Guanethidine,Sulfate, Guanethidine
D006892 Hydroxydopamines Dopamines with a hydroxy group substituted in one or more positions. Hydroxydopamine
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000831 Animals, Newborn Refers to animals in the period of time just after birth. Animals, Neonatal,Animal, Neonatal,Animal, Newborn,Neonatal Animal,Neonatal Animals,Newborn Animal,Newborn Animals

Related Publications

B A Pappas, and D A Peters, and A K Sobrian, and A Blouin, and B Drew
August 1983, European journal of pharmacology,
B A Pappas, and D A Peters, and A K Sobrian, and A Blouin, and B Drew
May 1985, Experimental neurology,
B A Pappas, and D A Peters, and A K Sobrian, and A Blouin, and B Drew
November 1990, Journal of the autonomic nervous system,
B A Pappas, and D A Peters, and A K Sobrian, and A Blouin, and B Drew
June 1985, Pharmacology, biochemistry, and behavior,
B A Pappas, and D A Peters, and A K Sobrian, and A Blouin, and B Drew
January 1983, Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova,
B A Pappas, and D A Peters, and A K Sobrian, and A Blouin, and B Drew
April 1972, Nature: New biology,
B A Pappas, and D A Peters, and A K Sobrian, and A Blouin, and B Drew
October 1978, Neuropharmacology,
B A Pappas, and D A Peters, and A K Sobrian, and A Blouin, and B Drew
October 1974, European journal of pharmacology,
B A Pappas, and D A Peters, and A K Sobrian, and A Blouin, and B Drew
June 2006, Brain research,
B A Pappas, and D A Peters, and A K Sobrian, and A Blouin, and B Drew
November 1984, Brain research,
Copied contents to your clipboard!